Healthtech Startups
16,987 companies tagged Healthtech, with their investors and founders.
RestorixHealth develops and operates wound care centers in partnership with hospitals, delivers professional wound care services in nursing facilities and home settings, and coordinates wound care supplies to improve patient access and outcomes.
2 investors
2 investors
Rev Genomics uses genomic selection, tissue culture, and molecular analysis to develop high-value crop cultivars for breeders and seed banks. The company creates novel plant phenotypes and provides molecular fingerprinting and breeding technology primarily for specialty crops in California.
2 investors
RevBio develops a biomimetic bone adhesive platform derived from marine biology for bone repair and regenerative applications across dental, orthopedic, and neurosurgical indications. The company is conducting first-in-human clinical trials on its regenerative bone glue technology.
2 investors
Reveleer provides a unified platform combining AI-powered retrieval, clinical intelligence, risk adjustment, and quality improvement tools for healthcare providers and health plans operating under value-based care models. The platform consolidates fragmented data and workflows to improve care quality, operational efficiency, and financial performance in Medicare value-based arrangements.
2 investors
Revisto offers an AI-driven platform that automates compliance review and approval of promotional and marketing materials for pharmaceutical companies, learning from regulations, industry best practices, and customer history. It aims to reduce review cycle time and support the creation of compliant, personalized content, and counts a Top 5 pharmaceutical company among its customers.
2 investors
RevMedica develops smart surgical stapling and soft tissue management systems for minimally invasive and robotic procedures, designed to provide real-time intraoperative data and improve clinical decision-making for surgeons. The platform aims to enhance patient safety and reduce operating room waste while maintaining environmental sustainability.
2 investors
Reyedar develops an AI-powered eye tracking system that detects biomarkers of neurological and visual health conditions such as glaucoma and Parkinson's disease through automated oculomotor testing. The company serves optometry centers, hospitals, clinics, and clinical research centers seeking rapid, non-invasive screening for neurovisual disorders.
2 investors
Rgenta develops orally available small molecule therapies that target RNA to address diseases previously considered undruggable, with programs in oncology (targeting proteins such as MYB in solid tumors and hematologic cancers) and central nervous system repeat expansion disorders like Huntington's disease. It operates in the RNA-targeted drug development space.
2 investors
Rhaeos develops FlowSense, a noninvasive wireless wearable skin patch that monitors fluid flow in the body, initially targeting hydrocephalus patients who depend on implantable shunts for cerebrospinal fluid management.
2 investors
Rhea is a healthcare platform providing integrated reproductive and fertility services for intended parents, combining medical care with personalized practitioner services.
2 investors
Cloud-based virtual cardiac care platform aggregating data from implantable and wearable devices with AI-assisted triage.
2 investors
Ribolia (ηεηη©) is a pioneer in RNAi technology and small nucleic acid drug development, with research platforms covering drug delivery, chemical modification, and multi-target drug development. The company serves patients with chronic diseases including cardiovascular, metabolic, kidney, and liver conditions through its siRNA pipeline.
2 investors
Ricovr Healthcare develops point-of-care diagnostic technology for fast, on-site testing aimed at improving workplace safety and healthcare. The company builds medical devices in the diagnostics space.
2 investors
Rigel is a biopharmaceutical company that develops and markets therapies including olutasidenib, pralsetinib, and fostamatinib for conditions such as acute myeloid leukemia and chronic immune thrombocytopenia. This page invites investigator-sponsored research proposals, offering study drug and/or monetary grants for independent studies aligned with Rigel's therapeutic areas.
2 investors
RingMD provides a telemedicine platform that lets healthcare organizations set up branded sites where patients can have video calls with doctors, schedule appointments, and receive e-prescriptions, notes, and medical certificates. It offers configurable onboarding, self-registration or admin approval options, and web and mobile access for medical personnel and patients.
2 investors
Rise Therapeutics develops oral immunotherapies, called Oral Immune BioModulators, using a synthetic biology-based drug design approach to treat autoimmune diseases and cancer. The company combines immunology research with in-house clinical GMP manufacturing and regulatory expertise to advance its pipeline through clinical validation.
2 investors
PromptWell offers an AI-native platform for healthcare organizations to turn routine member outreach into personalized, timely communications. It focuses on member engagement and healthcare education to help patients take an active role in their care.
2 investors
Mountain operates two health care brands (River and Loon) that deliver primary and behavioral care through technology and partnerships at low cost. River offers employers and groups comprehensive care starting at $35/month; Loon focuses on Medicaid enrollees and individuals with reproductive health services.
2 investors
Rivera provides independent oversight of pharmacy benefit manager (PBM) contracts by continuously monitoring 100% of pharmacy claims to recover overpayments and correct their root causes. It serves commercial and government health plans, employers, and channel partners in the U.S. healthcare and pharmacy benefits market.
2 investors
Rivermark Medical develops FloStent, a first-line device for treating benign prostatic hyperplasia (BPH) that is delivered during routine outpatient cystoscopy for urology practices and their patients. The device aims to restore urinary flow while preserving future treatment options.
2 investors
Rivet Health builds software to streamline billing and operations tasks in healthcare settings. The company serves healthcare billing teams and operations staff working at healthcare organizations.
2 investors
Rivio provides an AI-powered revenue cycle management service for hospitals, handling auditing, insurance claim submission, denial appeals, and hidden revenue recovery. It contractually guarantees full reimbursement from health insurance plans and serves the Brazilian healthcare market.
2 investors
RNA Diagnostics is a clinical-stage molecular diagnostics company developing a predictive biomarker platform to guide personalized cancer therapy management. The company's technology helps physicians optimize treatment decisions for cancer patients, particularly in breast cancer, to improve outcomes and reduce healthcare costs.
2 investors